These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7319678)

  • 1. Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma.
    Harding MW; Yang TJ
    Int J Cancer; 1981 Sep; 28(3):361-6. PubMed ID: 7319678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine transmissible venereal sarcoma: leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors at different stages of growth.
    Harding MW; Yang TJ
    Int J Cancer; 1981 Mar; 27(3):349-55. PubMed ID: 7026460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.
    Yang TJ; Palker TJ; Harding MW
    Cancer Immunol Immunother; 1991; 33(4):255-62. PubMed ID: 2059969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
    Kalafut F; Klobusická M; Novotná L
    Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
    Harding MW; Yang TJ
    Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity to the transmissible venereal tumor of the dog.
    Cohen D
    J Natl Cancer Inst; 1980 Feb; 64(2):317-21. PubMed ID: 6928223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity.
    Tank B; Marquet RL; Vennemans E; Westbroek DL
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immune complexes in sera of dogs with canine transmissible venereal sarcoma (CTVS) by a conglutinin-binding assay.
    Palker TJ; Yang TJ
    J Comp Pathol; 1985 Apr; 95(2):247-58. PubMed ID: 3915750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lymphocytes in spontaneous regression of experimentally transplanted canine transmissible venereal sarcoma.
    Mizuno S; Fujinaga T; Hagio M
    J Vet Med Sci; 1994 Feb; 56(1):15-20. PubMed ID: 8204742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectron microscopic localization of a tumor-associated antigen (TAA) in the canine transmissible venereal sarcoma by anti-TAA-antiferritin hybrid antibodies.
    Hill DL; Yang TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):725-32. PubMed ID: 3900513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and physicochemical characterization of a tumor-associated antigen from canine transmissible venereal sarcoma.
    Palker TJ; Yang TJ
    J Natl Cancer Inst; 1981 Apr; 66(4):779-87. PubMed ID: 6939924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The canine transmissible venereal tumor: a unique result of tumor progression.
    Cohen D
    Adv Cancer Res; 1985; 43():75-112. PubMed ID: 3887857
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor infiltrating lymphocytes: CD8+ lymphocytes in canine transmissible venereal sarcomas at different stages of tumor growth.
    Barber MR; Yang TJ
    Anticancer Res; 1999; 19(2A):1137-42. PubMed ID: 10368665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of humoral immunity in progressive and regressive and metastatic growth of the canine transmissible venereal sarcoma.
    Fenton MA; Yang TJ
    Oncology; 1988; 45(3):210-3. PubMed ID: 3368197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.
    Beschorner WE; Hess AD; Nerenberg ST; Epstein RB
    Cancer Res; 1979 Oct; 39(10):3920-7. PubMed ID: 476629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma.
    Yang TJ; Chandler JP; Dunne-Anway S
    Br J Cancer; 1987 Feb; 55(2):131-4. PubMed ID: 2949770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review).
    Yang TJ
    Anticancer Res; 1988; 8(1):93-5. PubMed ID: 3282476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.